Metabolic Flux Increases Glycoprotein Sialylation: Implications for Cell Adhesion and Cancer Metastasis*
暂无分享,去创建一个
Yuan Tian | Hui Zhang | Zhen Zhang | Matthew R. Dallas | K. Konstantopoulos | Ruben T. Almaraz | Rahul Bhattarcharya | Elaine Tan | Shih-Hsun Chen | Li Chen | K. Yarema
[1] A. Mariotti,et al. [The sialic acids]. , 1960, Minerva medica.
[2] S. Roseman,et al. The sialic acids. XI. A periodate-resorcinol method for the quantitative estimation of free sialic acids and their glycosides. , 1971, The Journal of biological chemistry.
[3] R K Craig,et al. Methods in molecular medicine. , 1987, British medical journal.
[4] T. A. Fritz,et al. Disaccharide uptake and priming in animal cells: inhibition of sialyl Lewis X by acetylated Gal beta 1-->4GlcNAc beta-O-naphthalenemethanol. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[5] B. Simon,et al. The α6-integrin receptor in pancreatic carcinoma☆ , 1995 .
[6] C. Goochee,et al. A mathematical model of sialylation of N-linked oligosaccharides in the trans-Golgi network. , 1997, Glycobiology.
[7] R. Kannagi,et al. Involvement of adhesion molecules in metastasis of SW1990, human pancreatic cancer cells , 1998, Journal of surgical oncology.
[8] M. Pawlita,et al. UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation. , 1999, Science.
[9] A. Sali,et al. Comparative protein structure modeling of genes and genomes. , 2000, Annual review of biophysics and biomolecular structure.
[10] K. Konstantopoulos,et al. Glycolipids support E-selectin-specific strong cell tethering under flow. , 2001, Biochemical and biophysical research communications.
[11] C. Bertozzi,et al. Metabolic selection of glycosylation defects in human cells , 2001, Nature Biotechnology.
[12] C. Bertozzi,et al. Substrate specificity of the sialic acid biosynthetic pathway. , 2001, Biochemistry.
[13] Ruedi Aebersold,et al. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry , 2003, Nature Biotechnology.
[14] J. Takagi,et al. Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[15] Mark B. Jones,et al. Characterization of the cellular uptake and metabolic conversion of acetylated N‐acetylmannosamine (ManNAc) analogues to sialic acids , 2004, Biotechnology and bioengineering.
[16] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[17] Alan J Wright,et al. Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. , 2004, Molecular cell.
[18] Mark B. Jones,et al. Characterization of the Metabolic Flux and Apoptotic Effects of O-Hydroxyl- and N-Acyl-modified N-Acetylmannosamine Analogs in Jurkat Cells* , 2004, Journal of Biological Chemistry.
[19] Claus-Wilhelm von der Lieth,et al. GlyProt: in silico glycosylation of proteins , 2005, Nucleic Acids Res..
[20] J. Wakefield,et al. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. , 2005, Cancer research.
[21] K. Konstantopoulos,et al. Variant isoforms of CD44 are P‐ and L‐selectin ligands on colon carcinoma cells , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] Y. Wada,et al. N-Glycosylation of the β-Propeller Domain of the Integrin α5 Subunit Is Essential for α5β1 Heterodimerization, Expression on the Cell Surface, and Its Biological Function* , 2006, Journal of Biological Chemistry.
[24] P. Tonali,et al. NCAM is hyposialylated in hereditary inclusion body myopathy due to GNE mutations , 2006, Neurology.
[25] K. Yarema,et al. Roles for UDP-GlcNAc 2-Epimerase/ManNAc 6-Kinase outside of Sialic Acid Biosynthesis , 2006, Journal of Biological Chemistry.
[26] Julia T. Chu,et al. HCELL Is the Major E- and L-selectin Ligand Expressed on LS174T Colon Carcinoma Cells* , 2006, Journal of Biological Chemistry.
[27] R. Aebersold,et al. Isolation of glycoproteins and identification of their N-linked glycosylation sites. , 2006, Methods in molecular biology.
[28] Yuan Tian,et al. Solid-phase extraction of N-linked glycopeptides , 2007, Nature Protocols.
[29] J. Dennis,et al. Complex N-Glycan Number and Degree of Branching Cooperate to Regulate Cell Proliferation and Differentiation , 2007, Cell.
[30] K. Yarema,et al. Metabolic oligosaccharide engineering: perspectives, applications, and future directions. , 2007, Molecular bioSystems.
[31] O. Florey,et al. Analysis of flow-based adhesion in vitro. , 2007, Methods in molecular medicine.
[32] K. Konstantopoulos,et al. Selectin Ligand Expression Regulates the Initial Vascular Interactions of Colon Carcinoma Cells , 2006, Journal of Biological Chemistry.
[33] B. Galeano,et al. Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine. , 2007, The Journal of clinical investigation.
[34] Udayanath Aich,et al. Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells. , 2008, Journal of medicinal chemistry.
[35] Ken S Lau,et al. N-Glycans in cancer progression. , 2008, Glycobiology.
[36] D. MacArthur,et al. UDP-N-Acetylglucosamine 2-Epimerase/N-Acetylmannosamine Kinase (GNE) Binds to Alpha-Actinin 1: Novel Pathways in Skeletal Muscle? , 2008, PloS one.
[37] K. Konstantopoulos,et al. Carcinoembryonic Antigen and CD44 Variant Isoforms Cooperate to Mediate Colon Carcinoma Cell Adhesion to E- and L-selectin in Shear Flow* , 2008, Journal of Biological Chemistry.
[38] Udayanath Aich,et al. Regioisomeric SCFA attachment to hexosamines separates metabolic flux from cytotoxicity and MUC1 suppression. , 2008, ACS chemical biology.
[39] Raja R Srinivas,et al. Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery. , 2009, Journal of medicinal chemistry.
[40] M. A. Meledeo,et al. Hexosamine analogs: from metabolic glycoengineering to drug discovery. , 2009, Current opinion in chemical biology.
[41] J. Dennis,et al. Metabolism, Cell Surface Organization, and Disease , 2009, Cell.
[42] F. J. Krambeck,et al. A mathematical model to derive N-glycan structures and cellular enzyme activities from mass spectrometric data. , 2009, Glycobiology.
[43] Jian Du,et al. Metabolic glycoengineering: sialic acid and beyond. , 2009, Glycobiology.
[44] C. Hackenberger,et al. Efficient metabolic oligosaccharide engineering of glycoproteins by UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) knock-down. , 2011, Molecular bioSystems.
[45] Cécile Boscher,et al. Glycosylation, galectins and cellular signaling. , 2011, Current opinion in cell biology.
[46] Udayanath Aich,et al. Metabolic oligosaccharide engineering with N‐Acyl functionalized ManNAc analogs: Cytotoxicity, metabolic flux, and glycan‐display considerations , 2012, Biotechnology and bioengineering.
[47] Yuan Tian,et al. Altered Expression of Sialylated Glycoproteins in Breast Cancer Using Hydrazide Chemistry and Mass Spectrometry* , 2012, Molecular & Cellular Proteomics.